Article from Fibromyalgia News Today: Novel Form of Extended-Release Gabapentin Improves Fibromyalgia Patients’ Pain Symptoms and Sleep Disorder Fibromyalgia News Today

This article which was published in Fibromyalgia News Today on June 18th 2015 and written by Patricia Inacio, PhD discusses ‘an open-label pilot study’ – ‘The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study‘, which tried out an extended-release form of Gabapentin called G-GR (gastroretentive gabapentin)  for the treatment of Fibromyalgia.  However, as it is suggested in the article, although it gave some interesting results more in-depth research is required but the article instils a little hope for the development of medicines for Fibromyalgia 🙂

Opening Paragraph:

In a new study entitled “The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study” researchers showed that administration of the drug gabapentin (in an extended-release approach), initially prescribed as an anti-epilepsy medication, relieved fibromyalgia-associated pain symptoms and improved fibromyalgia patients’ quality of life. The study was published in the journal Pain Practice.

Read the rest of the article via: Novel Form of Extended-Release Gabapentin Improves Fibromyalgia Patients’ Pain Symptoms and Sleep Disorder Fibromyalgia News Today.

Advertisements